Tag: Drug Approvals
FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritis
FDA Approves Dupixent for Bullous Pemphigoid
Benefits include sustained disease remission, reductions in itch, lower oral corticosteroids dose
FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma
Significantly improved progression-free survival seen with Monjuvi in combination with rituximab and lenalidomide
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
Approval marks first and only twice-yearly option available in the United States for PrEP
FDA Approves Once-Monthly Andembry for Hereditary Angioedema
The monoclonal antibody is a self-administered injection for prophylactic use to prevent attacks
FDA Offers Speedier Approvals to Drug Companies Aligning With ‘National Priorities’
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop...
Texas Invests $50M in Psychedelic Drug Research to Treat Addiction
FDA Approves Polypill Widaplik for Hypertension
Approval marks first triple-combination pill of telmisartan, amlodipine, and indapamide
Moderna’s New Lower-Dose COVID-19 Vaccine Approved by FDA
New vaccine represents a step forward in development of next-generation coronavirus vaccines
